XFLH Capital Corporation Announces the Signing of a Letter of Intent with Renogen Biolab Inc.

XFLH Capital Corporation, a Cayman Islands blank-check company, has signed a non-binding letter of intent for a business combination with Renogen Biolab Inc. Renogen is a Canadian health service provider offering core molecular capabilities including DNA services, vector engineering, and protein expression.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.